Literature DB >> 10809923

Progressive multifocal leukoencephalopathy: simultaneous detection of JCV DNA and anti-JCV antibodies in the cerebrospinal fluid.

B Guillaume1, C J Sindic, T Weber.   

Abstract

We report on a case of biopsy-proven progressive multifocal leukoencephalopathy (PML) in a patient without obvious immunodeficiency. Analysis of the cerebrospinal fluid revealed the simultaneous presence of JC virus DNA and of locally produced, anti-JC virus antibodies. The intrathecal humoral immune response increased throughout the course of the disease, whereas the detection of the JC genome became ultimately negative in spite of the continuous extension of the lesions with fatal outcome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809923     DOI: 10.1046/j.1468-1331.2000.00009.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  9 in total

1.  JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

Authors:  I J Koralnik; R A Du Pasquier; N L Letvin
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 2.  Progressive multifocal leukoencephalopathy and other forms of JC virus disease.

Authors:  Bruce J Brew; Nicholas W S Davies; Paola Cinque; David B Clifford; Avindra Nath
Journal:  Nat Rev Neurol       Date:  2010-12       Impact factor: 42.937

Review 3.  Immune response in progressive multifocal leukoencephalopathy: an overview.

Authors:  T Weber; F Weber; H Petry; W Lüke
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

4.  Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system.

Authors:  S M Gregoire; V van Pesch; S Goffette; A Peeters; C J M Sindic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-25       Impact factor: 10.154

5.  JC virus antibody status underestimates infection rates.

Authors:  Joseph R Berger; Sidney A Houff; Julie Gurwell; Nubia Vega; Craig S Miller; Robert J Danaher
Journal:  Ann Neurol       Date:  2013-08-06       Impact factor: 10.422

Review 6.  Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression.

Authors:  Sarah Gheuens; Gerald Pierone; Patrick Peeters; Igor J Koralnik
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10-14       Impact factor: 10.154

7.  JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy.

Authors:  R A Du Pasquier; K W Clark; P S Smith; J T Joseph; J M Mazullo; U De Girolami; N L Letvin; I J Koralnik
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 3.739

8.  Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a man with AIDS.

Authors:  Katie Yoganathan; David Brown; Kathir Yoganathan
Journal:  Int J Gen Med       Date:  2012-04-13

Review 9.  The importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathy.

Authors:  Elizabeth L Frost; Aron E Lukacher
Journal:  Front Immunol       Date:  2015-01-05       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.